Evidence map›Paper›PMID 41149313›Full record

ArticleBiosensors2025

MoS

Meimei Xu, Shuai Zhao, Yusi Peng, Yong Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meimei XuKey Laboratory of Liquid Crystal Polymers Based Flexible Display Technology in National Petroleum and Chemical Industry, Xi'an Key Laboratory of Advanced Photo-Electronics Materials and Energy Conversion Device, Technological Institute of Materials & Energy Science (TIMES), Xijing University, Xi'an 710123, China.
Shuai ZhaoState Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Dingxi Road, Shanghai 200050, China.
Yusi PengState Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Dingxi Road, Shanghai 200050, China.ORCID 0009-0008-0314-4954
Yong YangState Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Dingxi Road, Shanghai 200050, China.ORCID 0000-0001-8996-2182

Funding

National Key Research and Development Project No.2022YFE0110100Natural Science Fund No.52172167Shanghai Science and Technology Program No.22DX1900300Shanghai Science and Technology Program No.22XD1404000Youth Cultivation Project No.21QNPY151
6 · The paper itself

Abstract

The single colorimetric signal readout mode of traditional lateral flow immunoassay (LFIA), which relies on gold nanoparticles (Au NPs), is inadequate to meet the growing demand for detection in terms of sensitivity, accuracy, and flexibility. Herein, we reported a novel colorimetric and photothermal dual-mode LFIA (dLFIA) based on MoS

Indexed as

ColorimetryCoronavirus Nucleocapsid ProteinsCOVID-19DisulfidesMolybdenumSARS-CoV-2GoldHumansImmunoassayLimit of DetectionMetal NanoparticlesPhosphoproteinsReproducibility of ResultsCoronavirus Nucleocapsid ProteinsDisulfidesGoldMolybdenummolybdenum disulfidenucleocapsid phosphoprotein, SARS-CoV-2Phosphoproteinsdual-mode lateral flow immunoassayMoS2 nanoflowersphotothermalSARS-CoV-2 nucleocapsid protein

Identifiers

PMID41149313
PMCPMC12562453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.